Aptevo Therapeutics Inc. (APVO) vs Basel Medical Group Ltd Ordinary Shares (BMGL)
A side-by-side comparison of Aptevo Therapeutics Inc. and Basel Medical Group Ltd Ordinary Shares across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APVO
Aptevo Therapeutics Inc.
$1.80HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
BMGL
Basel Medical Group Ltd Ordinary Shares
$3.17HealthcareDelayed quote: Oct 5, 2026, 4:00 PM EDT
Total return — APVO vs BMGL
growth of $100 · dividends reinvested · last 2yAPVO -99.8% (-96.0%/yr)BMGL -94.1% (-75.6%/yr)BMGL compounded faster over this window
Log scale — wide-divergence pair
APVO BMGL
APVO vs BMGL: by the numbers
- •BMGL is the larger company ($5M vs $4M market cap).
- •Both run net losses; APVO's is the smaller (0.00% vs -106.78% net margin).
Metrics side by side
Valuation
| Metric | APVO | BMGL |
|---|---|---|
| P/B ratio | 0.65 | 1.02 |
Profitability
| Metric | APVO | BMGL |
|---|---|---|
| Gross margin | 0.00% | 77.68% |
| Operating margin | 0.00% | -19.28% |
| Net margin | 0.00% | -106.78% |
| ROE | -437.15% | -248.66% |
| ROIC | -288.14% | -35.07% |
Growth (annualized)
| Metric | APVO | BMGL |
|---|---|---|
| Total return CAGR (5Y) | -95.30% | N/A |
Go deeper
Dig into the metrics
Aptevo Therapeutics ROEBasel Medical Group Ltd Ordinary Shares ROEAptevo Therapeutics operating marginBasel Medical Group Ltd Ordinary Shares operating marginAptevo Therapeutics revenue growthBasel Medical Group Ltd Ordinary Shares revenue growthAptevo Therapeutics free cash flowBasel Medical Group Ltd Ordinary Shares free cash flow
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.